Nanomix and UC Berkeley Announce E-Nose Detection Collaboration

EMERYVILLE, Calif.--(BUSINESS WIRE)--March 16, 2006--Nanomix Inc., a leading nanotechnology company commercializing high-value detection applications, today announced it has signed a collaboration agreement with researchers at the University of California Berkeley to develop a novel electronic nose (E-Nose) diagnostic device. The agreement enables Nanomix to leverage its proprietary Sensation(TM) detection platform and further enhance its product development portfolio in point-of-care detection applications.

The collaboration agreement involves joint development of a device for clinical diagnosis of disease directly in the physician's office or outpatient clinic. Point-of-care diagnosis with an electronic olfactory sensor system based on a detection array can provide multiple advantages versus traditional lab-based techniques in terms of speed, convenience, cost, and improved patient outcomes.

“Collaborating with a world-class team like this one led by Dr. Noam Sobel at Berkeley is an important part of our application-driven commercialization strategy.”

"We are excited about our collaborative efforts with researchers at the Berkeley Olfactory Research Project, and are delighted with the prospects offered by this device in point-of-care diagnostic applications," stated David Macdonald, President and CEO of Nanomix. "Collaborating with a world-class team like this one led by Dr. Noam Sobel at Berkeley is an important part of our application-driven commercialization strategy."

"Incorporating the Sensation technology and working with Nanomix will assist us in bringing product application projects through to final development. We look forward to combining Nanomix technology and know-how with our extensive experience in electronic olfactory applications," said Dr. Noam Sobel, Associate Professor at the Helen Wills Neuroscience Institute at UC Berkeley.

About Nanomix

Nanomix is a leading nanotechnology company launching a portfolio of devices based on Sensation(TM) detection technology. These scaleable, nanoelectronic devices use ultra-sensitive carbon nanotube sensing elements combined with proprietary chemistries. These devices can be deployed across a broad range of industrial and medical applications where the attributes of nanodetection technology -- low power consumption, small form factor, and high sensitivity offer significant performance advantages and enable unprecedented access to critical information. Nanomix is located in Emeryville, California. For additional information, please visit the Nanomix web site at


Nanomix Inc.
Bill Perry, 510-428-5300

Better Be Business Wired.

Business Wire is the leading source for press releases, photos, multimedia and regulatory filings from companies and groups throughout the world.